Cargando…
Type 2 Diabetes and Testosterone Therapy
A third of men with type 2 diabetes (T2DM) have hypogonadotrophic hypogonadism (HH) and associated increased risk of cardiovascular and all-cause mortality. Men with HH are at increased risk of developing incident T2DM. We conducted MEDLINE, EMBASE, and COCHRANE reviews on T2DM, HH, testosterone def...
Autor principal: | Hackett, Geoffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Sexual Medicine and Andrology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305869/ https://www.ncbi.nlm.nih.gov/pubmed/30079639 http://dx.doi.org/10.5534/wjmh.180027 |
Ejemplares similares
-
Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile Function
por: Hackett, Geoffrey, et al.
Publicado: (2020) -
Testosterone and the Heart
por: Kirby, Michael, et al.
Publicado: (2019) -
Commentary on “Late-onset hypogonadism - beyond testosterone”
por: Hackett, Geoffrey
Publicado: (2015) -
Should All Men with Type 2 Diabetes Be Routinely Prescribed a Phosphodiesterase Type 5 Inhibitor?
por: Hackett, Geoffrey
Publicado: (2020) -
Increase in Osteocalcin Following Testosterone Therapy in Men With Type 2 Diabetes and Subnormal Free Testosterone
por: Ghanim, Husam, et al.
Publicado: (2019)